how the mpn field has evolved over the years: novel agents, trials, and more
Published 1 year ago • 172 plays • Length 2:06Download video MP4
Download video MP3
Similar videos
-
16:35
key highlights in mpns at ash 2023: novel agents & combinations, ongoing clinical trials, and more
-
1:44
upcoming trials and novel agents in mpns
-
1:31
novel treatment agents and how they're changing the mpn field
-
3:22
the latest clinical trials in the treatment of mpns
-
1:52
mpn updates: trial updates, combinations & novel therapies
-
2:28
updates in mpns from asco 2024: combination therapies, trial endpoints & future directions
-
13:05
finding hope in treatment: new developments in mpn research 2023
-
9:25
mgus diagnosis: a step-by-step approach
-
12:42
mpn clinical trials 2022 update
-
1:25
the current approach to managing patients with prefibrotic pmf
-
3:16
new mpn clinical trials & drugs in 2021
-
1:26
the future of jak inhibition for mpns
-
1:00
how genomic testing has influenced treatment approaches and clinical trial design in mpns
-
2:00
the role of fedratinib in 2024 and beyond
-
1:19
telomerase inhibition as a novel targeted therapy for myelofibrosis
-
2:13
the future of mpn treatment: exciting agents and targets being investigated
-
4:32
current trials in mpn in the uk and the launch of the mympnvoice app
-
1:18
updates in the treatment of r/r lbcl: promising novel agents in the pipeline
-
1:53
the latest clinical updates on navtemadlin for the treatment of mpns
-
2:28
how to approach the treatment of younger patients with mpn
-
1:31
pevaz update: pevonedistat & azacitidine in r/r mds and mds/mpn after dnmti failure